{
    "nctId": "NCT01771666",
    "briefTitle": "Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer",
    "officialTitle": "A Pilot Study to Assess the Utility of Indocyanine Green\u2122 (IC-GREEN\u2122) SPY Imaging in the Mapping of Arm Draining Lymphatics and Nodes During Sentinel Node Resection With or Without Axillary Dissection in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 23,
    "primaryOutcomeMeasure": "Agreement of Labeling Between Isosulfan Blue (IS-BLUE) and Indocyanine Green (IC-GREEN)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Ability to understand and the willingness to sign a written informed consent document.\n* Signed written informed consent.\n* Women undergoing sentinel lymph node biopsy.\n* Women with breast cancer with known or suspected lymph node involvement.\n* Women undergoing sentinel node identification and completion axillary lymph node dissection.\n* Women of 18 years of age or older.\n* Eastern Cooperative Oncology Group (ECOG) or Karnofsky Performance Status 0,1,2.\n* Complete Blood Count (CBC) and basic Metabolic Panel within 6 months\n\nExclusion Criteria:\n\n* History of liver or kidney failure will not be eligible.\n* Allergies to iodine containing products will not be eligible.\n* Women who are pregnant will not be eligible.\n* Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}